• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA

AROVELLA THERAPEUTICS LIMITED - Charts / Financials

6.33% ! 8.4¢
Market Cap $100.4M  !
Healthcare Biotechnology
Add to My Watchlist

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

refresh Created with Sketch. REFRESH
Day
Open 7.8¢   Day High 8.4¢   Day Low 7.8¢
Daily Volume 1216139
Bids   Sellers
Number Price Volume   Number Price Volume
1 8.2¢ 100000   1 8.4¢ 119034

Directors & Senior Management

Mr. Michael Baker Chief Executive Officer, Managing Director, Director
Mr. Tim Luscombe Chief Financial Officer, Company Secretary
Dr. Nicole van Der Weerden Chief Operating Officer
Dr. Elizabeth Stoner Non-Executive Chairman of the Board
Dr. Debora Barton Non-Executive Independent Director
Mr. Gary Jonathan Phillips Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.4¢ 		Change
0.005(6.33%) 		Mkt cap ! $100.4M
Open High Low Value Volume
7.8¢ 8.4¢ 7.8¢ $97.89K 1.216M

Buyers (Bids)

No. Vol. Price($)
1 100000 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 119034 1
View Market Depth
Last trade - 16.10pm 12/09/2025 (20 minute delay) ?

Top Stories

BSP Financial jumps as PNG PM Marape specifically names stock in gov't press release

Pacific-based banking company BSP Financial Group (ASX:BFL) has jumped +7% in morning trades on Friday as the company highlighted comments made by PNG PM James Marape to the effect of committing to a @strong banking sector.’ That really means @we’ll leave you mostl...
Week 37 Wrap: Markets often possess a poetic irony; warfare has brought back the 'circular economy' Welcome to HotCopper’s weekly wrap for Week 37 where it’s been another broadly dry week for the ASX200 as opposed to Wall Street, which appears to be tracking along per usual. That of course might not be too surprising given the stock market tends to retreat a litt...
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
HotCopper Highlights Week 37: LKY nextdoor to MP Materials; Service Stream's DoD win & more Good Afternoon and welcome to HotCopper Highlights for Week 37, I’m Jon Davidson. In this segment the stocks you were watching and discussing the most this week on Australia’s #1 finance website, let’s get into it starting with the most viewed.Servi...
WiseTech, COG, Neuren: All the biggest ASX director trades from the last week Welcome to HotCopper’s Director Trades column, where we take a look at all the most interesting director transactions from September 4-10.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.